Cuba created the vaccine in 2011 after 15 years of research. Brazil, Argentina and Colombia are currently applying to have access to the vaccine, while the U.K and Australia have already carried out their own clinical trials.
“Signing this agreement means we can immerse ourselves in clinical trials when we return to New York,” said Candance Johnson, director of the U.S.-based Roswell Park institute.
The agreement was signed as part of a business delegation visit to Cuba headed by New York Governor Andrew Cuomo.
Publish by The Ministry of Foreign Affairs of Cuba